Perceptive Life Sciences Master Fund Ltd - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp II (ARYBU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp II (ARYBU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYA Sciences Acquisition Corp II (ARYBU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in Athira Pharma Inc (ATHA) with a net purchase of 1,371,362. Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net purchase of 80,012 shares made by Andrew Gengos , a net purchase of 47,386 shares made by Glenna Mileson , and a net purchase of 38,000 shares made by Kelly A Romano .

In summary, during the past 3 months, insiders sold 0 shares of Athira Pharma Inc (ATHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,995 shares of Athira Pharma Inc (ATHA) were sold and 1,584,374 shares were bought by its insiders, resulting in a net purchase of 1,564,379 shares.

Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in Quotient Ltd (QTNTQ) with a net sale of 8,255,607. Other recent insider transactions involving Quotient Ltd (QTNTQ) include a net purchase of 975,000 shares made by Prondzynski Heino Von , a net sale of 3,223 shares made by Isabelle Buckle , and a net purchase of 4,666,666 shares made by L John Wilkerson .

In summary, during the past 3 months, insiders sold 0 shares of Quotient Ltd (QTNTQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 232,513 shares of Quotient Ltd (QTNTQ) were sold and 263,787 shares were bought by its insiders, resulting in a net purchase of 31,274 shares.

Quotient Ltd (QTNTQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Athenex Inc (ATNXQ). Other recent insider transactions involving Athenex Inc (ATNXQ) include a net purchase of 20,000 shares made by Lau Johnson Yiu Nam , and a net purchase of 10,000 shares made by Jinn Wu .

In summary, during the past 3 months, insiders sold 0 shares of Athenex Inc (ATNXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Athenex Inc (ATNXQ) were sold and 1,500 shares were bought by its insiders, resulting in a net purchase of 1,500 shares.

Athenex Inc (ATNXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in Albireo Pharma Inc (ALBO) with a net sale of 420,416. Other recent insider transactions involving Albireo Pharma Inc (ALBO) include a net sale of 4,593 shares made by Pamela Stephenson , a net sale of 2,462 shares made by Harford Simon N.r. , and a net sale of 4,731 shares made by Cooper Ronald Harold Wilfred .

In summary, during the past 3 months, insiders sold 0 shares of Albireo Pharma Inc (ALBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 442,788 shares of Albireo Pharma Inc (ALBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 442,788 shares.

Albireo Pharma Inc (ALBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 8 insider transaction in Aldeyra Therapeutics Inc (ALDX) with a net purchase of 1,305,206. Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net purchase of 17,700 shares made by Todd C Brady , a net purchase of 4,323 shares made by Martin Joseph Joyce ,

In summary, during the past 3 months, insiders sold 0 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 1,327,229 shares were bought by its insiders, resulting in a net purchase of 1,327,229 shares.

Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Leap Therapeutics Inc (LPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Leap Therapeutics Inc (LPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Leap Therapeutics Inc (LPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in VYNE Therapeutics Inc (VYNE). Other recent insider transactions involving VYNE Therapeutics Inc (VYNE) include a net purchase of 20,000 shares made by Patrick G Lepore , and a net purchase of 10,000 shares made by Mutya Harsch .

In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 30,000 shares were bought by its insiders, resulting in a net purchase of 30,000 shares.

VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 2 insider transaction in Lyra Therapeutics Inc (LYRA) with a net purchase of 9,535,002. Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include a net purchase of 4,293,566 shares made by Edward T Anderson , a net purchase of 4,175,083 shares made by Nbvm Gp, Llc , and a net purchase of 7,828 shares made by C Ann Merrifield .

In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 18,248,445 shares were bought by its insiders, resulting in a net purchase of 18,248,445 shares.

Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in VBI Vaccines Inc (VBIV) with a net sale of 10,894,749. Other recent insider transactions involving VBI Vaccines Inc (VBIV) include a net purchase of 609,090 shares made by Steven Gillis ,

In summary, during the past 3 months, insiders sold 0 shares of VBI Vaccines Inc (VBIV) in total and bought 609,090 shares, with a net purchase of 609,090 shares. During the past 18 months, 363,158 shares of VBI Vaccines Inc (VBIV) were sold and 609,090 shares were bought by its insiders, resulting in a net purchase of 245,932 shares.

VBI Vaccines Inc (VBIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in Crinetics Pharmaceuticals Inc (CRNX) with a net purchase of 157,515. Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 67,919 shares made by Stephen F. Betz , a net sale of 260,000 shares made by Richard Scott Struthers , and a net sale of 30,922 shares made by Marc Wilson .

In summary, during the past 3 months, insiders sold 50,000 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 50,000 shares. During the past 18 months, 373,905 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 162,515 shares were bought by its insiders, resulting in a net sale of 211,390 shares.

Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in ADMA Biologics Inc (ADMA). Other recent insider transactions involving ADMA Biologics Inc (ADMA) include a net sale of 730,507 shares made by Adam S Grossman , a net sale of 382,769 shares made by Brian Lenz , and a net sale of 1,433,304 shares made by Bryant Fong .

In summary, during the past 3 months, insiders sold 2,583,538 shares of ADMA Biologics Inc (ADMA) in total and bought 155,000 shares, with a net sale of 2,428,538 shares. During the past 18 months, 2,583,538 shares of ADMA Biologics Inc (ADMA) were sold and 191,958 shares were bought by its insiders, resulting in a net sale of 2,391,580 shares.

ADMA Biologics Inc (ADMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Agile Therapeutics Inc (AGRX). Other recent insider transactions involving Agile Therapeutics Inc (AGRX) include a net purchase of 50,000 shares made by Alfred Altomari ,

In summary, during the past 3 months, insiders sold 0 shares of Agile Therapeutics Inc (AGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Agile Therapeutics Inc (AGRX) were sold and 1,000 shares were bought by its insiders, resulting in a net purchase of 1,000 shares.

Agile Therapeutics Inc (AGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Kadmon Holdings Inc (KDMN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kadmon Holdings Inc (KDMN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kadmon Holdings Inc (KDMN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Dova Pharmaceuticals Inc (DOVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dova Pharmaceuticals Inc (DOVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dova Pharmaceuticals Inc (DOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in MeiraGTx Holdings PLC (MGTX) with a net purchase of 4,347,826. Other recent insider transactions involving MeiraGTx Holdings PLC (MGTX) include a net purchase of 5,000 shares made by Robert K Zeldin , a net purchase of 1,000 shares made by Robert J Wollin ,

In summary, during the past 3 months, insiders sold 0 shares of MeiraGTx Holdings PLC (MGTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MeiraGTx Holdings PLC (MGTX) were sold and 4,353,826 shares were bought by its insiders, resulting in a net purchase of 4,353,826 shares.

MeiraGTx Holdings PLC (MGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Foamix Pharmaceuticals Ltd (FOMX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Foamix Pharmaceuticals Ltd (FOMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Foamix Pharmaceuticals Ltd (FOMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Solid Biosciences Inc (SLDB). Other recent insider transactions involving Solid Biosciences Inc (SLDB) include a net sale of 2,010 shares made by Ilan Ganot , and a net sale of 441 shares made by Carl Ashley Morris .

In summary, during the past 3 months, insiders sold 0 shares of Solid Biosciences Inc (SLDB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,451 shares of Solid Biosciences Inc (SLDB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,451 shares.

Solid Biosciences Inc (SLDB)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Motus GI Holdings Inc (MOTS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Motus GI Holdings Inc (MOTS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Motus GI Holdings Inc (MOTS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 508,059 shares made by John F Crowley , a net sale of 202,438 shares made by Bradley L Campbell , and a net sale of 65,102 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 131,266 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 131,266 shares. During the past 18 months, 937,134 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 937,134 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of La Jolla Pharmaceutical Co (LJPC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of La Jolla Pharmaceutical Co (LJPC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

La Jolla Pharmaceutical Co (LJPC)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Corium International Inc (CORI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Corium International Inc (CORI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Corium International Inc (CORI)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Zogenix Inc (ZGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zogenix Inc (ZGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zogenix Inc (ZGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in Verrica Pharmaceuticals Inc (VRCA) with a net purchase of 1,428,571. Other recent insider transactions involving Verrica Pharmaceuticals Inc (VRCA) include a net sale of 26,289 shares made by Christopher G. Hayes , a net purchase of 200,000 shares made by Paul B Manning , and a net sale of 50,677 shares made by Ted White .

In summary, during the past 3 months, insiders sold 151,427 shares of Verrica Pharmaceuticals Inc (VRCA) in total and bought 200,000 shares, with a net purchase of 48,573 shares. During the past 18 months, 151,427 shares of Verrica Pharmaceuticals Inc (VRCA) were sold and 1,636,071 shares were bought by its insiders, resulting in a net purchase of 1,484,644 shares.

Verrica Pharmaceuticals Inc (VRCA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Global Blood Therapeutics Inc (GBT). Other recent insider transactions involving Global Blood Therapeutics Inc (GBT) include a net sale of 31,441 shares made by Jeffrey S Farrow , a net sale of 4,678 shares made by Nazila Habibizad , and a net sale of 1,908 shares made by Dawn Svoronos .

In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 39,287 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 39,287 shares.

Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in AcelRx Pharmaceuticals Inc (ACRX). Other recent insider transactions involving AcelRx Pharmaceuticals Inc (ACRX) include a net purchase of 56,400 shares made by Vincent J. Angotti , and a net sale of 16,956 shares made by Pamela P Palmer .

In summary, during the past 3 months, insiders sold 16,956 shares of AcelRx Pharmaceuticals Inc (ACRX) in total and bought 10,000 shares, with a net sale of 6,956 shares. During the past 18 months, 16,956 shares of AcelRx Pharmaceuticals Inc (ACRX) were sold and 12,320 shares were bought by its insiders, resulting in a net sale of 4,636 shares.

AcelRx Pharmaceuticals Inc (ACRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aegerion Pharmaceuticals Inc (AEGR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aegerion Pharmaceuticals Inc (AEGR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aegerion Pharmaceuticals Inc (AEGR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,486,744 shares made by Adam Morgan , and a net sale of 1,504 shares made by Kimberly Manhard .

In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 2,486,744 shares, with a net purchase of 2,486,744 shares. During the past 18 months, 1,504 shares of Heron Therapeutics Inc (HRTX) were sold and 2,486,744 shares were bought by its insiders, resulting in a net purchase of 2,485,240 shares.

Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of XTL Biopharmaceuticals Ltd (XTLB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XTL Biopharmaceuticals Ltd (XTLB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XTL Biopharmaceuticals Ltd (XTLB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in ANI Pharmaceuticals Inc (ANIP). Other recent insider transactions involving ANI Pharmaceuticals Inc (ANIP) include a net sale of 290,000 shares made by Muthusamy Shanmugam , a net sale of 80,000 shares made by Chad Gassert , and a net sale of 400,000 shares made by Meridian Venture Partners Ii Lp .

In summary, during the past 3 months, insiders sold 568,414 shares of ANI Pharmaceuticals Inc (ANIP) in total and bought 0 shares, with a net sale of 568,414 shares. During the past 18 months, 896,480 shares of ANI Pharmaceuticals Inc (ANIP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 896,480 shares.

ANI Pharmaceuticals Inc (ANIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Antares Pharma Inc (ATRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Antares Pharma Inc (ATRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Antares Pharma Inc (ATRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in SCYNEXIS Inc (SCYX). Other recent insider transactions involving SCYNEXIS Inc (SCYX) include a net purchase of 75,000 shares made by Marco Taglietti , and a net purchase of 3,500 shares made by Scott Sukenick .

In summary, during the past 3 months, insiders sold 0 shares of SCYNEXIS Inc (SCYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SCYNEXIS Inc (SCYX) were sold and 78,500 shares were bought by its insiders, resulting in a net purchase of 78,500 shares.

SCYNEXIS Inc (SCYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in Astria Therapeutics Inc (ATXS) with a net purchase of 908,265.

In summary, during the past 3 months, insiders sold 0 shares of Astria Therapeutics Inc (ATXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Astria Therapeutics Inc (ATXS) were sold and 908,265 shares were bought by its insiders, resulting in a net purchase of 908,265 shares.

Astria Therapeutics Inc (ATXS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in IsoPlexis Corp (ISO). Other recent insider transactions involving IsoPlexis Corp (ISO) include a net purchase of 50,253 shares made by Nachum Shamir , a net purchase of 20,000 shares made by Rew Richard W. Ii , and a net purchase of 15,000 shares made by Sean Mackay .

In summary, during the past 3 months, insiders sold 0 shares of IsoPlexis Corp (ISO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of IsoPlexis Corp (ISO) were sold and 95,253 shares were bought by its insiders, resulting in a net purchase of 95,253 shares.

IsoPlexis Corp (ISO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Prometheus Biosciences Inc (RXDX). Other recent insider transactions involving Prometheus Biosciences Inc (RXDX) include a net sale of 125,000 shares made by Mark C. Mckenna , a net sale of 30,000 shares made by Keith W Marshall , and a net sale of 865,000 shares made by Cedars Sinai Intellectual Property Co .

In summary, during the past 3 months, insiders sold 0 shares of Prometheus Biosciences Inc (RXDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,020,000 shares of Prometheus Biosciences Inc (RXDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,020,000 shares.

Prometheus Biosciences Inc (RXDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 164,881 shares made by Franklin M Berger , a net purchase of 1,710,358 shares made by Biotechnology Value Fund L P , and a net purchase of 1,088,273 shares made by Kevin C Tang .

In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 995,000 shares of Rain Oncology Inc (RAIN) were sold and 3,960,724 shares were bought by its insiders, resulting in a net purchase of 2,965,724 shares.

Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Landos Biopharma Inc (LABP). Other recent insider transactions involving Landos Biopharma Inc (LABP) include a net sale of 300,000 shares made by Rtw Investments, Lp ,

In summary, during the past 3 months, insiders sold 0 shares of Landos Biopharma Inc (LABP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 300,000 shares of Landos Biopharma Inc (LABP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 300,000 shares.

Landos Biopharma Inc (LABP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 1 insider transaction in Cerevel Therapeutics Holdings Inc (CERE) with a net purchase of 1,425,000. Other recent insider transactions involving Cerevel Therapeutics Holdings Inc (CERE) include a net sale of 450,000 shares made by N Anthony Coles , a net sale of 241,105 shares made by John Renger , and a net sale of 96,056 shares made by Abraham Ceesay .

In summary, during the past 3 months, insiders sold 100,000 shares of Cerevel Therapeutics Holdings Inc (CERE) in total and bought 105,737 shares, with a net purchase of 5,737 shares. During the past 18 months, 1,046,761 shares of Cerevel Therapeutics Holdings Inc (CERE) were sold and 1,530,737 shares were bought by its insiders, resulting in a net purchase of 483,976 shares.

Cerevel Therapeutics Holdings Inc (CERE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Nautilus Biotechnology Inc (NAUT). Other recent insider transactions involving Nautilus Biotechnology Inc (NAUT) include a net purchase of 100,000 shares made by Sujal M Patel , a net purchase of 90,000 shares made by Subramanian Sankar , and a net purchase of 23,000 shares made by Anna Mowry .

In summary, during the past 3 months, insiders sold 0 shares of Nautilus Biotechnology Inc (NAUT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nautilus Biotechnology Inc (NAUT) were sold and 253,000 shares were bought by its insiders, resulting in a net purchase of 253,000 shares.

Nautilus Biotechnology Inc (NAUT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 3 insider transaction in LianBio (LIAN) with a net purchase of 1,238,491.

In summary, during the past 3 months, insiders sold 0 shares of LianBio (LIAN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of LianBio (LIAN) were sold and 1,238,491 shares were bought by its insiders, resulting in a net purchase of 1,238,491 shares.

LianBio (LIAN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made no insider transaction in Acrivon Therapeutics Inc (ACRV). Other recent insider transactions involving Acrivon Therapeutics Inc (ACRV) include a net purchase of 392,035 shares made by Chione Ltd , and a net purchase of 3,389,500 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 16 shares of Acrivon Therapeutics Inc (ACRV) in total and bought 0 shares, with a net sale of 16 shares. During the past 18 months, 7,965 shares of Acrivon Therapeutics Inc (ACRV) were sold and 3,789,500 shares were bought by its insiders, resulting in a net purchase of 3,781,535 shares.

Acrivon Therapeutics Inc (ACRV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Perceptive Life Sciences Master Fund Ltd made 4 insider transaction in Soleno Therapeutics Inc (SLNO) with a net purchase of 343,298. Other recent insider transactions involving Soleno Therapeutics Inc (SLNO) include a net sale of 610,594 shares made by Jack W Schuler ,

In summary, during the past 3 months, insiders sold 0 shares of Soleno Therapeutics Inc (SLNO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 610,594 shares of Soleno Therapeutics Inc (SLNO) were sold and 343,298 shares were bought by its insiders, resulting in a net sale of 267,296 shares.

Soleno Therapeutics Inc (SLNO)'s detailed insider trading history can be found in Insider Trading Tracker table.